• L&C Bio executive Kim Ki-Min disclosed an increase in holdings of specific securities to 45,424 units, up from 40,000.
• Stake rose to 0.17% from 0.16%, based on a total share count of 26,969,704.
• Change reflected allocation of 5,424 “securities with subscription rights,” priced at KRW 39,100 per unit, dated Sept. 16, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. L&C Bio Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260923000205), on September 23, 2026, and is solely responsible for the information contained therein.